143 related articles for article (PubMed ID: 21534944)
1. Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.
Kim SY; Seong MW; Jeon BS; Kim SY; Ko HS; Kim JY; Park SS
Clin Genet; 2012 Jul; 82(1):77-82. PubMed ID: 21534944
[TBL] [Abstract][Full Text] [Related]
2. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.
Choi JM; Woo MS; Ma HI; Kang SY; Sung YH; Yong SW; Chung SJ; Kim JS; Shin HW; Lyoo CH; Lee PH; Baik JS; Kim SJ; Park MY; Sohn YH; Kim JH; Kim JW; Lee MS; Lee MC; Kim DH; Kim YJ
Neurogenetics; 2008 Oct; 9(4):263-9. PubMed ID: 18704525
[TBL] [Abstract][Full Text] [Related]
3. Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients.
Koziorowski D; Hoffman-Zacharska D; Sławek J; Jamrozik Z; Janik P; Potulska-Chromik A; Roszmann A; Tataj R; Bal J; Friedman A
Neurol Neurochir Pol; 2013; 47(4):319-24. PubMed ID: 23986421
[TBL] [Abstract][Full Text] [Related]
4. Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.
Huang T; Gao CY; Wu L; Gong PY; Wang JZ; Tian YY; Zhang YD
Brain Behav; 2019 Sep; 9(9):e01372. PubMed ID: 31386307
[TBL] [Abstract][Full Text] [Related]
5. Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients.
Djarmati A; Hedrich K; Svetel M; Schäfer N; Juric V; Vukosavic S; Hering R; Riess O; Romac S; Klein C; Kostic V
Hum Mutat; 2004 May; 23(5):525. PubMed ID: 15108293
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.
Monroy-Jaramillo N; Guerrero-Camacho JL; Rodríguez-Violante M; Boll-Woehrlen MC; Yescas-Gómez P; Alonso-Vilatela ME; López-López M
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):235-44. PubMed ID: 24677602
[TBL] [Abstract][Full Text] [Related]
7. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease.
Hedrich K; Djarmati A; Schäfer N; Hering R; Wellenbrock C; Weiss PH; Hilker R; Vieregge P; Ozelius LJ; Heutink P; Bonifati V; Schwinger E; Lang AE; Noth J; Bressman SB; Pramstaller PP; Riess O; Klein C
Neurology; 2004 Feb; 62(3):389-94. PubMed ID: 14872018
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.
Lin Y; Zeng YF; Cai NQ; Lin XZ; Wang N; He J
Eur Neurol; 2019; 81(5-6):246-253. PubMed ID: 31618739
[TBL] [Abstract][Full Text] [Related]
9. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
Ben-Shachar S; Afawi Z; Masalha R; Badarny S; Neiman T; Pavzner D; Bar-Shira A; Orr-Urtreger A
J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
[TBL] [Abstract][Full Text] [Related]
10. Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.
Elfferich P; Verleun-Mooijman MC; Maat-Kievit JA; van de Warrenburg BP; Abdo WF; Eshuis SA; Leenders KL; Hovestadt A; Zijlmans JC; Stroy JP; van Swieten JC; Boon AJ; van Engelen K; Verschuuren-Bemelmans CC; Lesnik-Oberstein SA; Tassorelli C; Lopiano L; Bonifati V; Dooijes D; van Minkelen R
Neurogenetics; 2011 Nov; 12(4):263-71. PubMed ID: 21993715
[TBL] [Abstract][Full Text] [Related]
11. Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: A case report.
Fang YQ; Mao F; Zhu MJ; Li XH
Medicine (Baltimore); 2019 Feb; 98(5):e14228. PubMed ID: 30702579
[TBL] [Abstract][Full Text] [Related]
12. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease.
Semenova EV; Shadrina MI; Slominsky PA; Ivanova-Smolenskaya IA; Bagyeva G; Illarioshkin SN; Limborska SA
Mov Disord; 2012 Jan; 27(1):139-42. PubMed ID: 21915905
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China.
Li H; Yusufujiang A; Naser S; Zhu Y; Maimaiti M; He X; Bu J; Meng X; Wang M; Li J; Dina B; Yang L; Nayi Z; Dang H; Wang C; Amiti D; Aji A; Yusufu N; Jiao Y; Duan F
J Neurol Sci; 2014 Jul; 342(1-2):21-4. PubMed ID: 24831986
[TBL] [Abstract][Full Text] [Related]
14. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
[TBL] [Abstract][Full Text] [Related]
15. Novel compound heterozygous mutations in the
Shi Y; Kawakami H; Zang W; Li G; Zhang J; Xu C
Brain Behav; 2018 Jan; 8(1):e00901. PubMed ID: 29568695
[TBL] [Abstract][Full Text] [Related]
16. Detection of compound heterozygous deletions in the parkin gene of fibroblasts in patients with autosomal recessive hereditary parkinsonism (PARK2).
Nakaso K; Adachi Y; Yasui K; Sakuma K; Nakashima K
Neurosci Lett; 2006 May; 400(1-2):44-7. PubMed ID: 16517073
[TBL] [Abstract][Full Text] [Related]
17. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
[TBL] [Abstract][Full Text] [Related]
18. Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.
Myhre R; Steinkjer S; Stormyr A; Nilsen GL; Abu Zayyad H; Horany K; Nusier MK; Klungland H
BMC Neurol; 2008 Dec; 8():47. PubMed ID: 19087301
[TBL] [Abstract][Full Text] [Related]
19. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
Sun M; Latourelle JC; Wooten GF; Lew MF; Klein C; Shill HA; Golbe LI; Mark MH; Racette BA; Perlmutter JS; Parsian A; Guttman M; Nicholson G; Xu G; Wilk JB; Saint-Hilaire MH; DeStefano AL; Prakash R; Williamson S; Suchowersky O; Labelle N; Growdon JH; Singer C; Watts RL; Goldwurm S; Pezzoli G; Baker KB; Pramstaller PP; Burn DJ; Chinnery PF; Sherman S; Vieregge P; Litvan I; Gillis T; MacDonald ME; Myers RH; Gusella JF
Arch Neurol; 2006 Jun; 63(6):826-32. PubMed ID: 16769863
[TBL] [Abstract][Full Text] [Related]
20. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
